Neoadjuvant chemoradiation therapy combined with immunotherapy for microsatellite stable ultra-low rectal cancer (CHOICE II): study protocol of a multicentre prospective randomised clinical trial

INTRODUCTION: Neoadjuvant chemoradiotherapy (nCRT) could bring tumour shrinking and downstaging and increase the probability of organ preservation for patients with low rectal cancer. But for ultra-low rectal cancer, there is little possibility for organ preservation. Immunotherapy has been shown to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Leqi, Yu, Guanyu, Wen, Rongbo, Jia, Hang, Zhang, Tianshuai, Peng, Zhiying, Fan, Hao, Pan, Anfu, Yu, Yue, Zhu, Xiaoming, Gong, Haifeng, Gao, Xianhua, Lou, Zheng, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503376/
https://www.ncbi.nlm.nih.gov/pubmed/37709314
http://dx.doi.org/10.1136/bmjopen-2022-069793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503376/
https://www.ncbi.nlm.nih.gov/pubmed/37709314
http://dx.doi.org/10.1136/bmjopen-2022-069793

Ejemplares similares